Polymorphisms of the 5HT2A and D2 receptor genes and weight change during olanzapine treatment

被引：0
|
作者：
Olajossy-Hilkesberger, L. [1 ]
Godlewska, B. [2 ]
Tylec, A. [3 ]
Olajossy, M. [3 ]
Marmurowska-Michalowska, H. [3 ]
机构：
[1] Med Univ Vienna Austria, Dept Psychiat & Psychotherapy, Div Biol Psychiat, Vienna, Austria
[2] Med Univ Gdansk, Dept Psychiat, Gdansk, Poland
[3] Med Univ Lublin, Dept Psychiat, Lublin, Poland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70656-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
  • [1] Genetic variants of the 5HT2A and D2 receptor genes and weight change during olanzapine treatment
    Olajossy-Hilkesberger, L
    Marmurowska-Michalowska, H
    Olajossy, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S474 - S475
  • [2] 5HT2A receptor polymorphisms and negative symptom response to olanzapine
    Perry, PJ
    Ellingrod, VL
    Bever-Stille, KA
    Lund, BC
    Miller, DD
    Fleming, FW
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 78 - 78
  • [3] 5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia
    Ellingrod, VL
    Perry, PJ
    Lund, BC
    Bever-Stille, K
    Pleming, F
    Holman, TL
    Miller, D
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (06) : 622 - 624
  • [4] Association between polymorphisms of the 5HT2A receptor gene and positive symptom response to olanzapine treatment in patients with schizophrenia
    Olajossy-Hilkesberger, L.
    Godlewska, B.
    Olajossy, M.
    Marmurowska-Michalowska, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S384 - S384
  • [5] Polymorphisms of the D2 and D3 receptor genes and clinical response to olanzapine
    Olajossy-Hilkesberger, Luiza
    Godlewska, Beata
    Olajossy, Marcin
    Marmurowska-Micha, Halina
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 787 - 787
  • [6] 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia:: A PET investigation
    Kapur, S
    Zipursky, RB
    Remington, G
    Jones, C
    DaSilva, J
    Wilson, AA
    Houle, S
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (07): : 921 - 928
  • [7] D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia:: a PET study
    Gefvert, O
    Lundberg, T
    Wieselgren, IM
    Bergström, M
    Långström, B
    Wiesel, FA
    Lindström, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (02) : 105 - 110
  • [8] Central D2 and 5HT2A occupancy of aripiprazole in patients with schizophrenia
    Mamo, D
    Graff, A
    Romeyer, F
    Shammi, CM
    Kapur, S
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 104 - 105
  • [9] Model structure–activity relationship studies of potential tropane 5HT1A, 5HT2A, and D2 receptor ligands
    Tomasz Słowiński
    Jacek Stefanowicz
    Martyna Z. Wróbel
    Franciszek Herold
    Andrzej Mazurek
    Franciszek Pluciński
    Aleksander P. Mazurek
    Irena Wolska
    Medicinal Chemistry Research, 2013, 22 : 3148 - 3153
  • [10] 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
    Noro, Magali
    Antonijevic, Irina
    Forray, Carlos
    Kasper, Siegfried
    Kocabas, Neslihan Aygun
    Lecrubier, Yves
    Linotte, Sylvie
    Mendlewicz, Julien
    Montgomery, Stuart
    Snyder, Lenore
    Souery, Daniel
    Verbanck, Paul
    Zohar, Joseph
    Massat, Isabelle
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (04) : 228 - 231
12345